| The Antitumor Immunity of Ipilimumab: (T cell) Memories to Last a Lifetime? | |
| | |
MedLine Citation:
|
PMID: 22338019 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Ipilimumab has demonstrated an overall survival benefit in two randomized phase III studies. A minority of patients achieve long-term disease control, highlighting the potential of this immunotherapeutic approach. Ongoing efforts continue to characterize these patients' unique clinical courses and correlate their responses with underlying mechanisms of antitumor immunity. |
| | |
Authors:
|
Michael A Postow; Margaret K Callahan; Jedd D Wolchok |
Related Documents
:
|
22404679 - Receptor signaling clusters in the immune synapse. 22786879 - Commitment to glycolysis sustains survival of no-producing inflammatory dendritic cells. 22718269 - Augmented lps responsiveness in type 1 diabetes-derived osteoclasts. 22328149 - Alternative pathway of cell death in drosophila mediated by nf-κb transcription factor... 22912669 - Withaferin a inhibits the proteasome activity in mesothelioma in vitro and in vivo. 22674989 - Kaposi's sarcoma-associated herpesvirus orf54/dutpase downregulates a ligand for the nk... 19593099 - Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. 21138749 - Mitochondrial targeting by use of lipid nanocapsules loaded with sv30, an analogue of t... 20018479 - Light, including ultraviolet. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-21 |
Journal Detail:
|
Title: Clinical cancer research : an official journal of the American Association for Cancer Research Volume: - ISSN: 1078-0432 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9502500 Medline TA: Clin Cancer Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Medicine, Memorial Sloan-Kettering Cancer Center. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy.
Next Document: ?2-Adrenergic receptor supports prolonged theta tetanus-induced LTP.